Senators Unveil Federal Marijuana Legalization Bill To Mixed Reviews, With White House Remaining Opposed

Marijuana advocates have been waiting anxiously for this day: Senate Majority Leader Chuck Schumer, Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker have released their draft bill to federally legalize marijuana.

Read more
Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy

Cybin’s latest patent application is in support of its proprietary digital therapeutics platform for mental health treatment.

Read more
Red Light Holland Sells Approximately 350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs to Six More Smart Shops

Red Light Holland announces that its iMicrodose Packs are now available in 30 storefronts and announces total sales of 350,000 grams of “magic truffles”.

Read more
DMT, active component in ayahuasca, aids in the growth of new neurons

In addition to being found naturally in animal tissues, including the human brain, N,N-dimethyltryptamine is the primary hallucinogenic compound found in the psychedelic brew known as ayahuasca.

Read more
Schumer To Unveil Federal Marijuana Legalization Bill On Wednesday

The leader of the U.S. Senate and colleagues will be releasing a discussion draft of a long-awaited bill to federally legalize cannabis on Wednesday, Marijuana Moment has learned.

Read more
Post-COVID Investment Mega-Opportunity: Mental Health and Psychedelic Drug Stocks

As COVID-19 recedes, a much larger pandemic has been exposed — the Mental Health Pandemic. A huge crisis; an enormous opportunity.

Read more
Let’s Defund The DEA

The U.S. Drug Enforcement Agency is a bureaucratic relic that regularly demonstrates it has no place in a world of 21st century drug reform.

Read more
MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company

MindMed’s new partnership with Datavant will enhance its data-collection/data-reporting as MindMed moves through its clinical trials.

Read more
Novamind Selected as Research Site for Bionomics’ PTSD Clinical Trial

Novamind’s clinics have been selected as a research site by atai-partner, Bionomics Limited for a Phase IIb clinical trial.

Read more
New Jersey to Allow Medical Cannabis Telemedicine Recommendations

New Jersey Gov. Phil Murphy has signed a law allowing medical cannabis recommendations to be made via telehealth services.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )